Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
162,927
-
Shares change
-
+32,044
-
Total reported value, excl. options
-
$530,000
-
Value change
-
+$103,853
-
Number of buys
-
3
-
Number of sells
-
-4
-
Price
-
$3.26
Significant Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q4 2019
11 filings reported holding ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value as of Q4 2019.
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 162,927 shares
of 66,587,586 outstanding shares and own 0.24% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (74,154 shares), STIFEL FINANCIAL CORP (22,599 shares), EDGEWOOD MANAGEMENT LLC (20,000 shares), VANGUARD GROUP INC (15,150 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (14,688 shares), BlackRock Inc. (10,549 shares), BANK OF MONTREAL /CAN/ (2,444 shares), MORGAN STANLEY (1,992 shares), UBS Group AG (780 shares), and NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (571 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.